Pseudohyperphosphatemia associated with high-dose liposomal amphotericin B therapy

Jason W. Lane, Nadja N. Rehak, Glen L. Hortin, Theoklis Zaoutis, Philip R. Krause, Thomas J. Walsh

Research output: Contribution to journalArticlepeer-review

22 Scopus citations


Background: Acute increases in serum inorganic phosphorus (Pi) up to 4.75 mmol/l in the absence of hypocalcemia and tissue deposition of calcium phosphate were noted in 3 patients receiving liposomal amphotericin B (L-AMB). We investigated L-AMB as a possible cause of pseudohyperphosphatemia. Methods: Serum samples from the index patient were analyzed for Pi content by our laboratory's primary analyzer (Synchron LX20) and by an alternate analyzer (Vitros). Clear and lipemic serum pools, and normal saline, were spiked with L-AMB and analyzed by the LX20 Pi method. Ultrafiltration studies were performed on patient and spiked sera. Results: Increased Pi values were obtained only from the LX20 analyzer. There was a direct linear relationship between the concentration of L-AMB in the spiked samples and the LX20 Pi results, indicating a 0.9 mmol/l Pi increase for every 100 mg/l increase in L-AMB. Ultrafiltration normalized the Pi results. Conclusion: Serum Pi results may be falsely increased in patients receiving L-AMB when measured by the LX20 analyzer. This novel cause of pseudohyperphosphatemia is due to interference of L-AMB with the method and is corrected by ultrafiltration of the specimen. Since the LX20 analyzer is widely used by the clinical laboratories clinicians and laboratory personnel should recognize this interference in order to avoid unnecessary diagnostic procedures and interventions.

Original languageEnglish (US)
Pages (from-to)145-149
Number of pages5
JournalClinica Chimica Acta
Issue number1-2
StatePublished - Jan 2008
Externally publishedYes


  • Liposomal amphotericin B (L-AMB)
  • Pseudohyperphosphatemia
  • Synchron LX20

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical


Dive into the research topics of 'Pseudohyperphosphatemia associated with high-dose liposomal amphotericin B therapy'. Together they form a unique fingerprint.

Cite this